Noncalcemic actions of 1,25-dihydroxyvitamin D3 and clinical applications
Open Access
- 31 August 1995
- Vol. 17 (2) , S107-S111
- https://doi.org/10.1016/8756-3282(95)00195-j
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Effect of topical calcipotriol on congenital ichthyosesBritish Journal of Dermatology, 1994
- An evaluation of 1,25-dihydroxyvitamin D3 analogues on the proliferation and differentiation of cultured human keratinocytes, calcium metabolism and the differentiation of human HL-60 cellsThe Journal of Nutritional Biochemistry, 1993
- Expression of 1,25-Dihydroxyvitamin D3 Receptors in Normal and Psoriatic SkinJournal of Investigative Dermatology, 1991
- Double-blind, right/left comparison of calcipotriol and betamethasone valerate in treatment of psoriasis vulgarisThe Lancet, 1991
- 1,25(OH)2D2 production by T lymphocytes and alveolar macrophages recovered by lavage from normocalcemic patients with tuberculosis.Journal of Clinical Investigation, 1990
- The noncalcemic analogue of vitamin D, 22-oxacalcitriol, suppresses parathyroid hormone synthesis and secretion.Journal of Clinical Investigation, 1989
- Vitamin D, its Precursors, and Metabolites do not Affect Melanization of Cultured Human MelanocytesJournal of Investigative Dermatology, 1988
- Defective binding and function of 1,25-dihydroxyvitamin D3 receptors in peripheral mononuclear cells of patients with end-organ resistance to 1,25-dihydroxyvitamin D.Journal of Clinical Investigation, 1985
- Target Cells for 1,25-Dihydroxyvitamin D 3 in Intestinal Tract, Stomach, Kidney, Skin, Pituitary, and ParathyroidScience, 1979
- 25-hydroxycholecalciferol stimulation of muscle metabolism.Journal of Clinical Investigation, 1975